None

POMS MES helps RoviSys expand life science capabilities

Manufacturing enterprise software integration services provider RoviSys is expanding its solutions range by forming a strategic collaboration to offer POMS Manufacturing Execution System (MES) to clie...

Rafinerija Nafte Brod Selects Technology from Honeywell's UOP and ExxonMobil Research and Engineering Company to Improve Quality of Refined Lubricants and Fuels

First initiative under new licensing alliance between Honeywell's UOP and ExxonMobil Research & Engineering Company UOP LLC, a Honeywell (NYSE: HON) company, and ExxonMobil Research and Engineerin...

NYSE, Honeywell CEOs call for action on 'fiscal cliff'

NEW YORK (Reuters) - U.S. politicians face a stark choice over the next six weeks: come together on a deal to avoid the fiscal cliff, or prepare for a recession as companies seek other places to inves...

RoviSys Partners with POMS MES to Expand Life Sciences Capabilities

AURORA, Ohio, March 22, 2013 /PRNewswire/ -- The RoviSys Company, a major life sciences and manufacturing automation integrator who works with a large number of pharmaceutical and biotechnology c...

RoviSys, POMS In MES Pact

Expands life sciences capabilities

Honeywell inks $735 million jet engine contract

Honeywell International Inc. said Wednesday that it got a $735 million contract to provide and maintain engines for the Israel Ministry of Defense's advanced jet trainer fleet.The F124 Turbofan engin...

Praxair Signs Agreement with Honeywell Resins & Chemicals

Praxair, Inc. (NYSE: PX) has signed a 15-year agreement with Honeywell Resins & Chemicals for the purchase of carbon dioxide, a by-product of Honeywell's caprolactam facility...

Gilat's Wavestream Wins Contract With Honeywell for In-flight Connectivity

PETAH TIKVA, Israel, Jan. 29, 2013 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq:GILT) announced today that its wholly owned subsidiary Wavestream® has been awarded an exclusive contract...

Identification of polyoxometalates as inhibitors of basic fibroblast growth factor.

Angiogenesis is the process of new blood vessel formation from pre-existing ones. Angiogenic factors contribute to neovascularization that takes place in angiogenesis-dependent diseases, including can...

Nanoscale polyoxometalate-based inorganic/organic hybrids.

The latest advances in the area of polyoxometalate (POM)-based inorganic/organic hybrid materials prepared by self-assembly, covalent modification, and supramolecular interactions are presented. This...

HIV-1 protease inhibition potential of functionalized polyoxometalates.

Polyoxometalates (POMs) are interesting biomedical agents due to their versatile anticancer and antiviral properties, such as remarkable anti-HIV activity. Although POMs are tunable and easily accessi...

Synthesis, characterisation and cytotoxicity of polyoxometalate/carboxymethyl chitosan nanocomposites.

Chitosan and its derivates continue to attract considerable research interest as effective drug carriers with good biocompatibility and high cellular uptake rates. We used these versatile features to...

Functionalized polyoxometalates with covalently linked bisphosphonate, N-donor or carboxylate ligands: from electrocatalytic to optical properties.

The structures of two families of hybrid organic-inorganic polyoxometalates (POMs) functionalized by covalently grafted carboxylate or bisphosphonate ligands are overviewed. The first family concerns...